U.S. Health Officials Continue Pause Of Johnson & Johnson Vaccine
NPRU.S. Health Officials Continue Pause Of Johnson & Johnson Vaccine Enlarge this image toggle caption Frederic J. Brown/AFP via Getty Images Frederic J. Brown/AFP via Getty Images An expert advisory committee to the Centers for Disease Control and Prevention decided Wednesday it needed more time to consider whether to recommend to resume administering the COVID-19 vaccine made by Johnson & Johnson. The committee's emergency meeting took place less than 36 hours after the CDC and the Food and Drug Administration called for a voluntary pause after receiving reports of serious side effects seen in six women who had received the Johnson & Johnson vaccine. Each developed a severe blood clotting disorder called cerebral venous sinus thrombosis within 6 to 13 days after receiving the vaccine. Sponsor Message CDC director Rochelle Walensky said that officials are working to reschedule vaccine appointments for people were going to receive the Johnson & Johnson vaccine during the pause.